| 26/11/2025 | OrbiMed Advisors V Limited | 1101(L) | +1,450,600(L) | | 24,260,100(L) | 14.34 | | 26/11/2025 | OrbiMed Asia GP V, L.P. | 1101(L) | +1,450,600(L) | | 24,260,100(L) | 14.34 | | 26/11/2025 | OrbiMed Asia Partners V, L.P. | 1101(L) | +1,450,600(L) | | 24,260,100(L) | 14.34 | | 24/11/2025 | 鄭攀 | 1213(L) | -10,530,757(L) | | 71,478,780(L) | 34.33 | | 24/11/2025 | 施永辉 | 1113(L) | +2,123,320(L) | | 2,123,320(L) | 1.02 | | 24/11/2025 | 杭州研泰投資合夥企業(有限合夥) | 1704(L) | | | 2,157,409(L) | 1.04 | | 24/11/2025 | 劉秀 | 1113(L) | +642,885(L) | | 642,885(L) | 0.31 | | 24/11/2025 | 于非 | 1113(L) | +2,269,008(L) | | 2,269,008(L) | 1.09 | | 19/11/2025 | OrbiMed Advisors V Limited | 1101(L) | +2,090,000(L) | | 22,760,100(L) | 13.45 | | 19/11/2025 | OrbiMed Asia GP V, L.P. | 1101(L) | +2,090,000(L) | | 22,760,100(L) | 13.45 | | 19/11/2025 | OrbiMed Asia Partners V, L.P. | 1101(L) | +2,090,000(L) | | 22,760,100(L) | 13.45 | | 19/11/2025 | 鄭攀 | 1201(L) | -2,090,000(L) | HKD 6.900(L) | 38,700,719(L) | 22.88 | | 13/11/2025 | OrbiMed Asia Partners V, L.P. | 1101(L) | +900,000(L) | | 20,670,100(L) | 12.22 | | 13/11/2025 | OrbiMed Asia GP V, L.P. | 1101(L) | +900,000(L) | | 20,670,100(L) | 12.22 | | 13/11/2025 | OrbiMed Advisors V Limited | 1101(L) | +900,000(L) | | 20,670,100(L) | 12.22 | | 13/11/2025 | 鄭攀 | 1201(L) | -900,000(L) | HKD 6.040(L) | 40,790,719(L) | 24.11 | | 12/09/2025 | CDBI Partners Fund II, L.P. | 1201(L) | -93,200(L) | HKD 8.610(L) | 8,396,831(L) | 4.96 | | 12/09/2025 | CD Capital Healthcare FUND V, L.P. | 1201(L) | -93,200(L) | HKD 8.610(L) | 8,396,831(L) | 4.96 | | 12/09/2025 | CD Capital GP Ltd | 1201(L) | -93,200(L) | HKD 8.610(L) | 8,396,831(L) | 4.96 | | 12/09/2025 | CDBI Partners Fund I, L.P. | 1201(L) | -93,200(L) | HKD 8.610(L) | 8,396,831(L) | 4.96 | | 12/09/2025 | CDBI GP, Ltd | 1201(L) | -93,200(L) | HKD 8.610(L) | 8,396,831(L) | 4.96 | | 12/09/2025 | CDBI Partners GP, Ltd | 1201(L) | -93,200(L) | HKD 8.610(L) | 8,396,831(L) | 4.96 | | 12/09/2025 | Master Summer Limited | 1201(L) | -93,200(L) | HKD 8.610(L) | 8,396,831(L) | 4.96 | | 16/05/2025 | Qiming Venture Partners V, L.P. | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | | 16/05/2025 | QM32 Limited | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | | 16/05/2025 | Qiming GP V, L.P. | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | | 16/05/2025 | Qiming Corporate GP V, Ltd. | 1201(L) | -6,956,748(L) | | 15,190,018(L) | 34.76 | | 08/05/2025 | Suzhou Qicheng Investment Management Partnership (Limited Partnership) | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | | 08/05/2025 | 于佳 | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | | 08/05/2025 | Suzhou Qiming Ronghe Venture Capital Partnership (Limited Partnership) | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | | 08/05/2025 | Shanghai Qichang Investment Consulting Co., Ltd. | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | | 08/05/2025 | 胡旭波 | 1201(L) | -5,043,252(L) | | 11,011,913(L) | 5.29 | | 22/04/2025 | LAV Kecheng Hong Kong Limited | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | | 22/04/2025 | LAV Corporate VI GP Opportunities, Ltd. | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | | 22/04/2025 | LAV Fund VI Opportunities, L.P. | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | | 22/04/2025 | LAV GP VI Opportunities, L.P. | 1001(L) | +3,000,000(L) | | 3,000,000(L) | 6.87 | | 22/04/2025 | Shanghai Liyao Investment Management Co., Ltd (上海礼曜投资管理有限公司) | 1101(L) | | | 24,776,804(L) | 11.90 | | 22/04/2025 | 陈飞 | 1101(L) | | | 24,776,804(L) | 11.90 | | 22/04/2025 | 施毅 | 1101(L) | +3,000,000(L) | | 20,091,680(L) | 45.98 | | 07/03/2025 | OrbiMed Advisors V Limited | 1101(L) | +4,589,900(L) | HKD 4.990(L) | 19,651,800(L) | 11.61 | | | 1 2 |
|